SCHEMBL27404166

SCHEMBL27404166

O=C(O)CC1CC1c1cccc(F)c1F

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.60
HTR2B P41595 4/20 0.60
ITGB3 P05106 2/20 0.41
ITGAV P06756 2/20 0.41
ITGB6 P18564 2/20 0.41
CES2 O00748 1/20 0.37
BCHE P06276 1/20 0.37
CES1 P23141 1/20 0.37
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.35
SLC6A12 P48065 2/20 0.35
SLC6A11 P48066 2/20 0.35
SLC6A13 Q9NSD5 2/20 0.35
RIPK1 Q13546 1/20 0.35
KDM1A O60341 2/20 0.35
KDM1B Q8NB78 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326980 0.81 ITGB3 (0.43) HTR2CHTR2BITGB3ITGAVITGB6
SCHEMBL23993632 0.77 HTR2C (0.68) HTR2CHTR2BHTR2ASLC6A4KDM1A
SCHEMBL6320155 0.77 ITGB3 (0.49) HTR2CHTR2BITGB3ITGAVITGB6
SCHEMBL2432912 0.73 FFAR1 (0.53) HTR2CHTR2BPPARDHTR2A
SCHEMBL14527911 0.70 PTGDR2 (0.57) HTR2CHTR2BHTR2A
SCHEMBL14774665 0.69 KDM1A (0.70) HTR2CHTR2BKDM1AKDM1B
SCHEMBL6327011 0.68 HTR2A (0.45) HTR2CHTR2BITGB3ITGAVITGB6
SCHEMBL27270387 0.67 SLC6A12 (0.39) HTR2CHTR2BITGB3ITGAVITGB6
SCHEMBL27404051 0.67 HTR2C (0.40) HTR2CHTR2BITGB3ITGAVITGB6
SCHEMBL12035570 0.67 ITGB3 (0.39) HTR2CHTR2BITGB3ITGAVITGB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130064-A1 SUBSTITUTED TETRAHYDROPYRROLO-PYRIDINONE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS Karuna Therapeutics, Inc. (US) 2024-06-20 WO disclosed